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Introduction: Recent research has shown that adiponectin levels in patients with schizophrenia vary 
similar to the general population. Moreover, antipsychotic medication may influence adiponectin levels, 
independent of metabolic parameters. We hypothesise different antipsychotics might vary in their effect 
on adiponectin levels independent of BMI and metabolic syndrome (MetS) status. 
Methods: 113 patients, with similar baseline demographic and metabolic characteristics, received either 
risperidone (n=54) or olanzapine (n=59). They were followed prospectively for 12 weeks. Adiponectin 
levels as well as general metabolic parameters were measured at baseline, 6 weeks and 12 weeks. 
Results: We observed a significant treatment by time interaction, showing an adiponectin increase in the 
risperidone treated patients and an adiponectin decrease in olanzapine treated patients. This effect was 
independent of BMI and the presence/absence of the metabolic syndrome. There was a significant 
association between fall in adiponectin and increase in waist circumference in the Olanzapine treated 
group (Figure 1).There was no change in HOMA-IR as a measure of insulin resistance in either group. 
[Figure 1]
Conclusion: We observed a differential effect of antipsychotic treatment (risperidone vs olanzapine) on 
adiponectin levels over time,independent of BMI (and MetS) suggesting an effect of olanzapine on 
adipose tissues, similar to what has been observed in animals models. The effects on adiponectin levels 
may partly explain the increased rates of obesity with Olanzapine. 
